Skip to content
10-Q

Quarterly Report

Biostax Corp.

0001493152-23-016620

← back to feed
Filed
May 12, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · May 12, 2023 83.3M sh
Cash And Equivalents Q1 2023 · Mar 31, 2023 $34.99K
Cash And Equivalents Q1 2023 · Dec 31, 2022 $150.49K
Current Liabilities Q1 2023 · Mar 31, 2023 $3.58M
Current Liabilities Q1 2023 · Dec 31, 2022 $3.48M
Total Liabilities Q1 2023 · Mar 31, 2023 $3.58M
Total Liabilities Q1 2023 · Dec 31, 2022 $3.48M
Current Assets Q1 2023 · Mar 31, 2023 $34.99K
Current Assets Q1 2023 · Dec 31, 2022 $150.49K
Total Assets Q1 2023 · Mar 31, 2023 $796.73K
Total Assets Q1 2023 · Dec 31, 2022 $963.72K
Shares Diluted Q1 2023 · Mar 31, 2022 483.71K sh
Operating Cash Flow Q1 2023 · Mar 31, 2022 −$57K
Stockholders Equity Q1 2023 · Mar 31, 2022 −$10.87M
Stockholders Equity Q1 2023 · Dec 31, 2021 −$7.95M
Eps Diluted Q1 2023 · Mar 31, 2022 −$5.29
Eps Basic Q1 2023 · Mar 31, 2022 −$5.29
Sga Expense Q1 2023 · Mar 31, 2022 $181.62K
Net Income Q1 2023 · Mar 31, 2022 −$2.56M
Operating Income Q1 2023 · Mar 31, 2022 −$181.62K